These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3182341)

  • 1. Radiotherapy alone for oropharyngeal carcinomas: the role of fraction size (2 Gy vs 2.5 Gy) on local control and early and late complications.
    Thomas F; Ozanne F; Mamelle G; Wibault P; Eschwege F
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1097-102. PubMed ID: 3182341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.
    Maciejewski B; Withers HR; Taylor JM; Hliniak A
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):831-43. PubMed ID: 2921175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of the radicality of resection and dose of postoperative radiation therapy on local control and survival in carcinomas of the upper aerodigestive tract.
    Pfreundner L; Willner J; Marx A; Hoppe F; Beckmann G; Flentje M
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1287-97. PubMed ID: 10889383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
    Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes.
    Wang CC
    Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1143-6. PubMed ID: 3384716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
    Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
    Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late toxicity of radiotherapy in Hodgkin's disease. The role of fraction size.
    Cosset JM; Henry-Amar M; Girinski T; Malaise E; Dupouy N; Dutreix J
    Acta Oncol; 1988; 27(2):123-9. PubMed ID: 3390343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial.
    Olmi P; Crispino S; Fallai C; Torri V; Rossi F; Bolner A; Amichetti M; Signor M; Taino R; Squadrelli M; Colombo A; Ardizzoia A; Ponticelli P; Franchin G; Minatel E; Gobitti C; Atzeni G; Gava A; Flann M; Marsoni S
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):78-92. PubMed ID: 12504039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local control of T3 carcinomas after accelerated fractionation: a look at the "gap".
    Wang CC; Efird J; Nakfoor B; Martins P
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):439-41. PubMed ID: 8655365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of different variants of hyperfractionated irradiation in cancer of the naso- and oropharynx and of the oral mucosa].
    Aliev BM; Chuprik-Malinovskaia TP; Aleknavichius EE
    Med Radiol (Mosk); 1988 Jun; 33(6):37-41. PubMed ID: 3386429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative radiotherapy for squamous cell carcinoma of the maxillary sinus: analysis of local control and late complications.
    Ogawa K; Toita T; Kakinohana Y; Adachi G; Kojya S; Itokazu T; Shinhama A; Matsumura J; Murayama S
    Oncol Rep; 2001; 8(2):315-9. PubMed ID: 11182047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma.
    Smith RV; Goldman SY; Beitler JJ; Wadler SS
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):831-6. PubMed ID: 15262759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of conventional fractionation (five fractions per week) and altered fractionation (six fractions per week) in stage I and II squamous cell carcinoma of oropharynx: An institutional study.
    Poddar J; Sharma AD; Kunikullaya SU; Neema JP
    Indian J Cancer; 2017; 54(1):6-10. PubMed ID: 29199652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics--a phase II multicenter study.
    Antognoni P; Bignardi M; Cazzaniga LF; Poli AM; Richetti A; Bossi A; Rampello G; Barbera F; Soatti C; Bardelli D; Giordano M; Danova M
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1137-45. PubMed ID: 8985036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13.
    Cox JD; Pajak TF; Marcial VA; Hanks GE; Mohiuddin M; Fu KK; Byhardt RW; Rubin P
    Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):515-21. PubMed ID: 2180866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
    Garden AS; Morrison WH; Ang KK; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx.
    Ang KK; Peters LJ; Weber RS; Maor MH; Morrison WH; Wendt CD; Brown BW
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1339-45. PubMed ID: 2262355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects.
    Maciejewski B; Withers HR; Taylor JM; Hliniak A
    Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):101-11. PubMed ID: 2298613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.